CompuGroup Financial Statements From 2010 to 2024
| CMPUY Stock | USD 32.38 0.00 0.00% |
Check CompuGroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CompuGroup main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . CompuGroup financial statements analysis is a perfect complement when working with CompuGroup Medical Valuation or Volatility modules.
CompuGroup |
CompuGroup Medical SE OTC Stock Operating Margin Analysis
CompuGroup Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CompuGroup Medical Operating Margin | 0.08 % |
Most of CompuGroup Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CompuGroup Medical SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CompuGroup Medical SE has an Operating Margin of 0.0841%. This is 100.24% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The operating margin for all United States stocks is 101.53% lower than that of the firm.
CompuGroup Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CompuGroup Medical's current stock value. Our valuation model uses many indicators to compare CompuGroup Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CompuGroup Medical competition to find correlations between indicators driving CompuGroup Medical's intrinsic value. More Info.CompuGroup Medical SE is number one stock in return on equity category among related companies. It is rated second in return on asset category among related companies reporting about 0.29 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CompuGroup Medical SE is roughly 3.49 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CompuGroup Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CompuGroup Medical's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CompuGroup Medical's earnings, one of the primary drivers of an investment's value.About CompuGroup Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include CompuGroup Medical income statement, its balance sheet, and the statement of cash flows. CompuGroup Medical investors use historical funamental indicators, such as CompuGroup Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although CompuGroup Medical investors may use each financial statement separately, they are all related. The changes in CompuGroup Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CompuGroup Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CompuGroup Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CompuGroup Medical. Please read more on our technical analysis and fundamental analysis pages.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugroup Medical is traded on OTC Exchange in the United States.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CompuGroup Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CompuGroup Medical's short interest history, or implied volatility extrapolated from CompuGroup Medical options trading.
Pair Trading with CompuGroup Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CompuGroup Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CompuGroup Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with CompuGroup OTC Stock
| 0.83 | MTHRF | M3 Inc | PairCorr |
Moving against CompuGroup OTC Stock
| 0.9 | GEHC | GE HealthCare Techno | PairCorr |
| 0.89 | TM | Toyota Motor Financial Report 8th of May 2024 | PairCorr |
| 0.76 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
| 0.72 | WF | Woori Financial Group Financial Report 21st of May 2024 | PairCorr |
| 0.66 | KB | KB Financial Group Earnings Call Today | PairCorr |
The ability to find closely correlated positions to CompuGroup Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CompuGroup Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CompuGroup Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CompuGroup Medical SE to buy it.
The correlation of CompuGroup Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CompuGroup Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CompuGroup Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CompuGroup Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of CompuGroup Medical Correlation against competitors. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for CompuGroup OTC Stock analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |